INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,400,680 | +60.5% | 206,000 | +37.3% | 1.04% | -5.3% |
| Q4 2022 | $5,233,500 | -25.2% | 150,000 | +20.0% | 1.10% | -19.2% |
| Q3 2022 | $6,995,000 | +61.8% | 125,000 | +49.7% | 1.36% | +52.9% |
| Q2 2022 | $4,322,000 | +18.9% | 83,495 | +67.0% | 0.89% | -6.0% |
| Q1 2022 | $3,634,000 | -38.5% | 50,000 | 0.0% | 0.95% | -42.2% |
| Q4 2021 | $5,912,000 | -11.9% | 50,000 | 0.0% | 1.64% | -15.1% |
| Q3 2021 | $6,708,000 | +38.1% | 50,000 | +66.7% | 1.93% | +44.2% |
| Q2 2021 | $4,857,000 | -64.4% | 30,000 | -82.4% | 1.34% | -65.7% |
| Q1 2021 | $13,643,000 | +318.0% | 170,000 | +183.3% | 3.90% | +301.4% |
| Q4 2020 | $3,264,000 | – | 60,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |